Apex Biotechnology Corp. Stock Price

TWSE:1733 Community·NT$3.1b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

1733 Share Price Performance

NT$30.75

2.85 (10.22%)

NT$30.75

2.85 (10.22%)

NT$30.75

Sun, 16 Nov 25

Share Pricen/a

1733 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Flawless balance sheet with proven track record.

3 Risks

2 Rewards

View Full Analysis

Apex Biotechnology Corp. Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: 1.51
: 28.44%
: 7.72%
: 0%

View Full Analysis

About 1733

Founded: 1997
Employees: n/a
CEO: Yanshi Shen
WebsiteView website: www.apexbio.com

Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. The company offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing, and hemosmart gold hemoglobin screening systems. It also provides pesticide residue check systems; and care management and tele-health services. The company was incorporated in 1997 and is headquartered in Hsinchu City, Taiwan.